Levin Capital Strategies’s GSK GSK Stock Holding History

Levin Capital Strategies’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,283	Closed	-$500	–	312
2016 Q3	$500	Hold	9,283	–	–	0.01%	226
2016 Q2	$503K	Hold	9,283	–	–	0.01%	223
2016 Q1	$471K	Sell	9,283 -37,960	-80%	-$1.89M	0.01%	230
2015 Q4	$2.38M	Hold	47,243	–	–	0.04%	144
2015 Q3	$2.27M	Hold	47,243	–	–	0.04%	153
2015 Q2	$2.46M	Hold	47,243	–	–	0.04%	154
2015 Q1	$2.73M	Hold	47,243	–	–	0.04%	155
2014 Q4	$2.52M	Hold	47,243	–	–	0.04%	163
2014 Q3	$2.71M	Hold	47,243	–	–	0.04%	160
2014 Q2	$3.16M	Hold	47,243	–	–	0.05%	162
2014 Q1	$3.15M	Hold	47,243	–	–	0.05%	150
2013 Q4	$3.15M	Hold	47,243	–	–	0.05%	146
2013 Q3	$2.96M	Hold	47,243	–	–	0.05%	141
2013 Q2	$2.95M	Buy	+47,243	New	+$3M	0.05%	139

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Levin Capital Strategies's GSK Position: Q4 2016 in Review

Levin Capital Strategies sold out of GSK (GSK) in Q4 2016, closing a stake of 9,283 shares — an estimated $500 sold.

Levin Capital Strategies first reported a position in GSK in Q2 2013 and held it in 14 quarters. The position peaked at $3.16M in Q2 2014. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

Levin Capital Strategies reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
Levin Capital Strategies sold 9,283 GSK shares in Q4 2016, an estimated $500.
Levin Capital Strategies first reported a position in GSK in Q2 2013 and held it in 14 quarters.
Levin Capital Strategies's GSK position peaked at $3.16M in Q2 2014.
762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Levin Capital Strategies's 13F filing for Q4 2016, filed 14 Feb 2017.